BACKGROUND: There is high variability in post-stroke aphasia severity and predicting recovery remains imprecise. Standard prognostics do not include neurophysiological indicators or genetic biomarkers of neuroplasticity, which may be critical sources of variability. OBJECTIVE: To evaluate whether a common polymorphism (Val66Met) in the gene for brain-derived neurotrophic factor (BDNF) contributes to variability in post-stroke aphasia, and to assess whether BDNF polymorphism interacts with neurophysiological indicators of neuroplasticity (cortical excitability and stimulation-induced neuroplasticity) to improve estimates of aphasia severity. METHODS: Saliva samples and motor-evoked potentials (MEPs) were collected from participants with chronic aphasia subsequent to left-hemisphere stroke. MEPs were collected prior to continuous theta burst stimulation (cTBS; index for cortical excitability) and 10 minutes following cTBS (index for stimulation-induced neuroplasticity) to the right primary motor cortex. Analyses assessed the extent to which BDNF polymorphism interacted with cortical excitability and stimulation-induced neuroplasticity to predict aphasia severity beyond established predictors. RESULTS: Val66Val carriers showed less aphasia severity than Val66Met carriers, after controlling for lesion volume and time post-stroke. Furthermore, Val66Val carriers showed expected effects of age on aphasia severity, and positive associations between severity and both cortical excitability and stimulation-induced neuroplasticity. In contrast, Val66Met carriers showed weaker effects of age and negative associations between cortical excitability, stimulation-induced neuroplasticity and aphasia severity. CONCLUSIONS: Neurophysiological indicators and genetic biomarkers of neuroplasticity improved aphasia severity predictions. Furthermore, BDNF polymorphism interacted with cortical excitability and stimulation-induced neuroplasticity to improve predictions. These findings provide novel insights into mechanisms of variability in stroke recovery and may improve aphasia prognostics.
BACKGROUND: There is high variability in post-stroke aphasia severity and predicting recovery remains imprecise. Standard prognostics do not include neurophysiological indicators or genetic biomarkers of neuroplasticity, which may be critical sources of variability. OBJECTIVE: To evaluate whether a common polymorphism (Val66Met) in the gene for brain-derived neurotrophic factor (BDNF) contributes to variability in post-stroke aphasia, and to assess whether BDNF polymorphism interacts with neurophysiological indicators of neuroplasticity (cortical excitability and stimulation-induced neuroplasticity) to improve estimates of aphasia severity. METHODS: Saliva samples and motor-evoked potentials (MEPs) were collected from participants with chronic aphasia subsequent to left-hemisphere stroke. MEPs were collected prior to continuous theta burst stimulation (cTBS; index for cortical excitability) and 10 minutes following cTBS (index for stimulation-induced neuroplasticity) to the right primary motor cortex. Analyses assessed the extent to which BDNF polymorphism interacted with cortical excitability and stimulation-induced neuroplasticity to predict aphasia severity beyond established predictors. RESULTS: Val66Val carriers showed less aphasia severity than Val66Met carriers, after controlling for lesion volume and time post-stroke. Furthermore, Val66Val carriers showed expected effects of age on aphasia severity, and positive associations between severity and both cortical excitability and stimulation-induced neuroplasticity. In contrast, Val66Met carriers showed weaker effects of age and negative associations between cortical excitability, stimulation-induced neuroplasticity and aphasia severity. CONCLUSIONS: Neurophysiological indicators and genetic biomarkers of neuroplasticity improved aphasia severity predictions. Furthermore, BDNF polymorphism interacted with cortical excitability and stimulation-induced neuroplasticity to improve predictions. These findings provide novel insights into mechanisms of variability in stroke recovery and may improve aphasia prognostics.
Authors: Brenton Hordacre; Duncan Austin; Katlyn E Brown; Lynton Graetz; Isabel Pareés; Stefania De Trane; Ann-Maree Vallence; Simon Koblar; Timothy Kleinig; Michelle N McDonnell; Richard Greenwood; Michael C Ridding; John C Rothwell Journal: Neurorehabil Neural Repair Date: 2021-02-12 Impact factor: 3.919
Authors: Riemke G A de Boer; Kerstin Spielmann; Majanka H Heijenbrok-Kal; Rick van der Vliet; Gerard M Ribbers; W Mieke E van de Sandt-Koenderman Journal: Neurorehabil Neural Repair Date: 2017-08-17 Impact factor: 3.919
Authors: Shu-Chen Li; Christian Chicherio; Lars Nyberg; Timo von Oertzen; Irene E Nagel; Goran Papenberg; Thomas Sander; Hauke R Heekeren; Ulman Lindenberger; Lars Bäckman Journal: J Cogn Neurosci Date: 2010-10 Impact factor: 3.225
Authors: Ahmad R Hariri; Terry E Goldberg; Venkata S Mattay; Bhaskar S Kolachana; Joseph H Callicott; Michael F Egan; Daniel R Weinberger Journal: J Neurosci Date: 2003-07-30 Impact factor: 6.167
Authors: Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger Journal: Cell Date: 2003-01-24 Impact factor: 41.582
Authors: Shahid Bashir; Jennifer M Perez; Jared C Horvath; Cleofe Pena-Gomez; Marine Vernet; Anuhya Capia; Miguel Alonso-Alonso; Alvaro Pascual-Leone Journal: Front Aging Neurosci Date: 2014-06-10 Impact factor: 5.750
Authors: Julius Fridriksson; Jordan Elm; Brielle C Stark; Alexandra Basilakos; Chris Rorden; Souvik Sen; Mark S George; Michelle Gottfried; Leonardo Bonilha Journal: Brain Stimul Date: 2018-08-18 Impact factor: 8.955
Authors: Bruce Crosson; Amy D Rodriguez; David Copland; Julius Fridriksson; Lisa C Krishnamurthy; Marcus Meinzer; Anastasia M Raymer; Venkatagiri Krishnamurthy; Alexander P Leff Journal: J Neurol Neurosurg Psychiatry Date: 2019-05-04 Impact factor: 10.154